NorthRock Partners LLC Sells 2,253 Shares of CVS Health Corporation $CVS

NorthRock Partners LLC decreased its position in shares of CVS Health Corporation (NYSE:CVS) by 15.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,984 shares of the pharmacy operator’s stock after selling 2,253 shares during the quarter. NorthRock Partners LLC’s holdings in CVS Health were worth $827,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Hazlett Burt & Watson Inc. raised its holdings in CVS Health by 10.9% during the 2nd quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after purchasing an additional 165 shares during the last quarter. Essex Financial Services Inc. increased its stake in shares of CVS Health by 0.8% in the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator’s stock valued at $1,403,000 after acquiring an additional 166 shares in the last quarter. Williams Financial LLC increased its stake in shares of CVS Health by 2.5% in the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock valued at $478,000 after acquiring an additional 167 shares in the last quarter. Hemington Wealth Management increased its stake in shares of CVS Health by 33.7% in the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 172 shares in the last quarter. Finally, Sumitomo Life Insurance Co. increased its stake in shares of CVS Health by 1.0% in the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator’s stock valued at $1,159,000 after acquiring an additional 174 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Jefferies Financial Group lifted their price objective on shares of CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, June 30th. Morgan Stanley lifted their price objective on shares of CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a research note on Tuesday. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Sunday, September 21st. Finally, Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $81.05.

CVS Health Price Performance

Shares of NYSE:CVS opened at $79.67 on Wednesday. The company’s 50-day moving average is $72.95 and its 200 day moving average is $67.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The company has a market capitalization of $101.05 billion, a P/E ratio of 22.25, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $79.94.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date is Thursday, October 23rd. CVS Health’s payout ratio is currently 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.